In conclusion, the present study shows that AF patients at high risk of stroke disclose low and high levels of APN and sCD40L, respectively, suggesting a role for APN in favoring platelet activation in vivo in this clinical setting. The gene discussed is CD40LG; the disease is stroke disorder.